Muzaffar Madny

Title: Muzaffar Madny: Innovator in Pharmaceutical Composition

Introduction

Muzaffar Madny is a notable inventor based in Gandhinagar, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that aid in the management of diabetes. His work is characterized by a focus on improving glycemic control in adults with type 2 diabetes mellitus.

Latest Patents

Muzaffar holds a patent for a pharmaceutical composition of alogliptin and metformin. This invention relates to a stable pharmaceutical composition that comprises an intimate mixture of alogliptin and metformin, along with suitable pharmaceutically acceptable excipients. The formulation specifies that metformin is present in about 3.3 parts or more by weight relative to 100 parts by weight of the total weight of the part comprising alogliptin. The invention also encompasses various processes for preparing this pharmaceutical composition and its application in enhancing glycemic control.

Career Highlights

Muzaffar is currently associated with Torrent Pharmaceuticals Limited, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing effective treatments for diabetes, showcasing his commitment to improving patient outcomes.

Collaborations

Some of his notable coworkers include Jaya Abraham and Suryakant Navale, who contribute to the collaborative efforts in research and development at Torrent Pharmaceuticals Limited.

Conclusion

Muzaffar Madny's contributions to pharmaceutical innovations, particularly in diabetes management, highlight his role as a key inventor in the industry. His patent for the composition of alogliptin and metformin represents a significant advancement in the field.